Deoxyribonucleic acid (DNA) nucleophilic site (DNA)

Nucleophilic sites on DNA sequences represent critical chemical targets for a broad class of antineoplastic drugs known as alkylating agents (StatPearls, 2023). These sites, primarily located on the nitrogen and oxygen atoms of purine and pyrimidine bases, possess high electron density, making them susceptible to attack by electrophilic molecules (NCBI, 2022). The N7 position of guanine is the most reactive and frequently modified site, followed by the N3 of adenine and the O6 of guanine (PubChem, 2023). When drugs covalently bind to these positions, they form DNA adducts that interfere with essential biological processes such as DNA replication and transcription. This interference results in DNA strand breaks, interstrand or intrastrand cross-linking, and base-pairing errors, which collectively trigger cell cycle arrest and apoptosis (PubMed, 2021). While highly effective against rapidly proliferating malignant cells, the non-specific nature of targeting DNA nucleophilic sites leads to significant side effects, including myelosuppression and the potential for therapy-related secondary malignancies (NIH, 2023). Understanding the reactivity of these sites is fundamental to the design of chemotherapy and the study of environmental mutagenesis.

Other names

DNA alkylation sitesNucleophilic centers of DNAGuanine N7 siteDNA basesNucleophilic positions in DNA

Drugs targeting these sites act as electrophiles that form covalent bonds with nucleophilic centers, such as the N7 position of guanine, leading to DNA adduct formation, interstrand or intrastrand cross-linking, and subsequent inhibition of DNA replication and transcription (StatPearls, 2023).